DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma eIF3a in DLBC: Prognostic Biomarker +Therapeutic Target Apr 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Enhancing CAR-T Therapy With Nivolumab: Final Analysis Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Combination Therapy: HDT/ASCT With CNCT19 Apr 25, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Predictive Model: DLBCL Mortality Risk Factors Apr 23, 2024
